Three-Dimensional Correction Methods for Idiopathic Scoliosis in Adolescent (NCT07366996) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Three-Dimensional Correction Methods for Idiopathic Scoliosis in Adolescent
Egypt30 participantsStarted 2026-02-01
Plain-language summary
This study aims to compare the effectiveness of "Schroth method" and "Scientific Exercise Approach to Scoliosis" for correcting idiopathic scoliosis in adolescents.
Who can participate
Age range
13 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Teenagers diagnosed with typical idiopathic scoliosis.
* Teenagers aged 13 to 18 years
* Both genders will be included.
* Participants with a Cobb angle ranging from 10° to 25°, as determined by radiographic analysis.
* Participants with Risser sign of 2 to 3, indicating incomplete skeletal maturity.
* Participants must be able to understand and follow instructions, ensuring effective participation in the treatment protocol.
Exclusion Criteria:
* Adolescents with significant visual or auditory impairments that could interfere with the ability to participate in or benefit from the rehabilitation programs.
* Adolescents with cognitive, mental, or psychological disorders that hinder understanding or following the instructions necessary for the treatment protocol.
* Adolescents who have previously undergone spinal surgery or any surgical interventions related to scoliosis or other spinal conditions.
* Adolescents with non-idiopathic scoliosis or scoliosis secondary to other underlying conditions (e.g., neuromuscular, congenital, or syndromic scoliosis).
* Adolescents with fixed spinal deformities that are not amenable to correction through non-surgical 3D approach.
* Adolescents with concurrent musculoskeletal conditions that could interfere with the treatment or assessment of scoliosis (e.g., significant hip or knee deformities).
* Adolescents currently participating in other clinical trials or receiving treatments that might confound the study results.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.